Annual report pursuant to Section 13 and 15(d)

Schedule of Segments (Tables)

Schedule of Segments (Tables)

12 Months Ended

Dec. 31, 2016

Schedule of Segment Reporting Information, by Segment

The Company also has certain small cancer related legacy investments and an investment in note receivable from a non-affiliated party that is included in the Corporate and Eliminations section below:

		Cannabis and Medical Marijuana Segment		Trash Management		Corporate and Eliminations		Consolidated
2016
Net sales	$	-	$	2,740,187	$	21,058	$	2,761,245
Operating income (loss)		(50,043)		34,485		(880,416)		(895,974)
Interest income		10,958		1		103,877		114,836
Interest expense		-		17,275		23,350		40,625
Total assets		1,632,055		1,119,407		2,627,137		5,378,599
Property additions		-		29,210		1,029		30,239
Depreciation and amortization		295		21,752		3,715		25,762
2015
Net sales	$	98,533	$	2,463,225	$	-	$	2,561,758
Operating income (loss)		(5,373)		122,488		(889,328)		(772,213)
Interest income		9,318		-		65,732		75,050
Interest expense		-		18,910		(3,278)		15,632
Total assets		1,673,616		1,131,481		1,469,964		4,275,061
Property additions		2,026		9,959		6,036		18,021
Depreciation and amortization		1,568		30,004		3,783		35,355